Analysis of wild-type and mutant p21WAF-1 gene activities

Molecular and Cellular Biology

Volumn 16, Issue 4, 1996, Pages 1786-1793

  Lin, Jiayuh ^a   Reichner, Cristina ^a   Wu, Xiangwei ^a,b   Levine, Arnold J ^a  

^a PRINCETON UNIVERSITY   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN P24; CYCLIN DEPENDENT KINASE; CYCLINE; INHIBITOR PROTEIN; MUTANT PROTEIN; PROTEIN P21; PROTEIN P53; TRANSCRIPTION FACTOR;

ARTICLE; CANCER CELL CULTURE; CELL CYCLE; CELL GROWTH; GENE EXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SITE DIRECTED MUTAGENESIS; TUMOR SUPPRESSOR GENE;

AMINO ACID SEQUENCE; CELL DIVISION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; GENES, P53; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0029928180     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.16.4.1786     Document Type: Article

References (49)

1. Baker, S. J., S. Markowitz, E. R. Fearon, J. K. U. Willson, and B. Vogelstein. 1990. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 249:912-915.
2. Baldin, V., J. Lukas, M. J. Marcote, M. Pagano, and G. Draetta. 1993. Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev. 7:812-821
3. Chen, J., P. K. Jackson, M. W. Kirschner, and A. Dutta. 1995. Separate domains of p21 involved in the inhibition of cdk kinase and PCNA. Nature (London) 374:386-388.
4. Diller, L., J. Kassel, C. E. Nelson, M. A. Gryka, G. Litwak, M. Gebhardt, B. Bressac, M. Ozturk, S. J. Baker, B. Vogelstein, and S. H. Friend. 1990. p53 functions as a cell cycle control protein in osteosarcomas. Mol. Cell. Biol. 10:5772-5781.
5. Dowdy, S. F., P. W. Hinds, K. Louie, S. I. Reed, A. Arnold, and R. A. Weinberg. 1993. Physical interaction of the retinoblastoma protein with human D cyclins. Cell 73:499-511.
6. Draetta, G. F. 1990. Cell cycle control in eukaryotes: molecular mechanism of cdc2 activation. Trends Biochem. Sci. 15:378-383.
7. Dulic, V., W. K. Kaufmann, S. J. Lees, T. D. Tisty, E. Lees, J. W. Harper, S. J. Elledge, and S. I. Reed. 1994. p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell 76:1013-1023
8. El-Deiry, W. S., T. Tokino, V. E. Velculescu, D. B. Levy, R. Parsons, J. M. Trent, D. Lin, W. E. Mercer, K. W. Kinzler, and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825.
9. Eliyahu, U., D. Michalovitz, S. Eliyahu, O. Pinhasi-Kimhi, and M. Oren. 1989. Wild-type p53 can inhibit oncogen-mediated focus formation Proc. Natl. Acad Sci. USA 86:8763-8767.
10. Evan, G. I., A. H. Wyllie, C. S. Gilbert, T. D. Littlewood, H. Land, M. Brooks, C. M. Waters, L. Z. Penn, and D. C. Hancock. 1992. Induction of apoptosis in fibroblasts by c-myc protein. Cell 69:119-128.
11. Ewen, M. E., H. K. Sluss, C. J. Sherr, H. Matsushime, J.-Y. Kato, and D. M. Livingston. 1993. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell 73:487-497.
12. Fields, S., and S. K. Jang. 1990. Presence of a potent transcription activating sequence in the p53 protein. Science 249:1046-1049.
13. Finlay, C. A., P. W. Hinds, and A. J. Levine. 1989 The p53 proto-oncogene can act as a suppressor of transformation. Cell 57:1083-1093.
14. Cip1 cyclin-dependent kinase inhibitor. Oncogene 10:2281-2287
15. Graham, F. L., and A. J. van der Eb. 1973. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52:455-467.
16. Halevy, O., B. G. Novitch, D. B. Spicer, S. X. Skapek, J. Rhee, G. J. Hannon, D. Beach, and A. B. Lassar. 1995. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by myoD. Science 267:1018-1021
17. Harper, J. W., G. R. Adami, N. Wei, K. Keyomarsi, and S. J. Elledge. 1993 The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805-816.
18. Hinds, P. W., S. Mittnacht, V. Dulie, A. Arnold, S. I. Reed, and R. A. Weinberg. 1992 Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell 70:993-1006.
19. Koff, A., A. Giordano, D. Desai, K. Yamashita, J. W. Harper, S. Elledge, T. Nisimoto, D. O. Morgan, B. R. Franza, and J. M. Roberts. 1992. Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle Science 257:1689-1693.
20. 19a. Kunkel, T. A. 1985. Rapid and efficient site-specific mutagenesis without phenotypic selection. Proc. Natl Acad. Sci. USA 82:488-492.
21. kip2 a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution Genes Dev. 9:639-649
22. Levine, A. J., J. Momand, and C. A. Finlay. 1991. The p53 tumor suppressor gene. Nature (London) 351:453-456
23. Li, R., S. Waga, G. J. Hannon, D. Beach, and B. Stillman. 1994. Differential effects by the p21 cdk inhibitor on PCNA-dependent DNA replication and repair Nature (London) 371:534-537
24. 22a. Lin, J., and A. J. Levine. Unpublished data
25. Cip1. Nature (London) 375:159-161.
26. Macleod, K. F., N. Sherry, G. Hannon, D. Beach, T. Tokino, K. Kinzler, B. Vogelstein, and T. Jacks. 1995. p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev 9:935-944.
27. Martinez, J., I. Georgoff, J. Martinez, and A. J. Levine. 1991. Cellular localization and cell cycle regulation by a temperature sensitive p53 protein. Genes Dev. 5:151-159.
28. Masuda, H., C. Miller, H. P. Koeffler, H. Battifora, and M. J. Cline. 1987 Rearrangement of the p53 gene in human osteogenic sarcomas Proc. Natl Acad. Sci. USA 84:7716-7719.
29. cip-1 cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev. 9:650-662.
30. Michalovitz, D., O. Halevy, and M. Oren. 1990. Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53. Cell 62:671-680
31. Mitsudomi, T., S. M. Steinberg, M. M. Nau, D. Carbone, D. D'Amico, S. Bodner, H. K. Oie, R. I. Linnoila, J. L. Mulshine, J. D. Minna, and A. F. Gazdar. 1992 p53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features Oncogene 7:171-180.
32. Miyashita, T., and J. C. Reed. 1995. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80:293-299
33. Nakanishi, M., R. S. Robetorye, G. R. Adami, O. M. Pereira-Smith, and J. R. Smith. 1995. Identification of the active region of the DNA synthesis inhibitory gene p21(sdi1/cip1/WAF1). EMBO J. 14:555-563
34. Nova, A., Y. Ning, S. F. Venable, O. M. Pereira-Smith, and J. R. Smith. 1994 Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp. Cell Res. 211:90-98.
35. Owen-Schaub, L. B., W. Zhang, J. C. Cusack, L. S. Angelo, S. M. Santee, T. Fujiwara, J. A. Roth, A. B. Deisseroth, W. W. Zhang, E. Kruzel, and R. Radinsky. 1995. Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression. Mol. Cell Biol. 15:3032-3040.
36. cip-1 in muscle and other terminally differentiating cells. Science 267:1024-1027.
37. Peter, M., A. Gartner, J. Horecka, G. Ammerer, and I. Herskowitz. 1993 Far1 links the signal transduction pathway to the cell cycle machinery in yeast. Cell 73:747-760
38. Pines, J., and T. Hunter. 1990. Human cyclin A is adenovirus E1A-associated protein p60 and behaves differently from cyclin B Nature (London) 346:760-763
39. kip-1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78:59-66
40. Raycroft, L., H. Wu, and G. Lozano. 1990. Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene. Science 249:1049-1051.
41. Sanger, F., S. Nicklen, and A. R. Coulson. 1977. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74:5463-5467
42. Sherr, C. J. 1993. Mammalian G1 cyclins Cell 73:1059-1065.
43. Skapek, S. X., J. Rhee, D. B. Spicer, and A. B. Lassar. 1995. Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase. Science 267:1022-1024.
44. Smith, M. L., I.-T. Chen, Q. Zhan, I. Bae, C.-Y. Chen, T. M. Gilmer, M. B. Kastan, P. M. O'Connor, and A. J. Fornace, Jr. 1994 Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen. Science 266:1376-1378.
45. Toyoshima, H., and T. Hunter. 1994. p27, a novel inhibitor of G1 cyclin-cdk protein kinase activity, is related to p21. Cell 78:67-74.
46. WAP-1 and proliferating cell nuclear antigen. Curr. Biol. 5:275-282.
47. Wu, X., and A. J. Levine. 1994. p53 and E2F-1 cooperate to mediate apoptosis. Proc. Natl. Acad. Sci. USA 91:3602-3606.
48. Xiong, Y., G. J. Hannon, H. Zhang, D. Casso, R. Kobayashi, and D. Beach. 1993. p21 is a universal inhibitor of cyclin kinases. Nature (London) 366: 701-704
49. Waf is contained in its N-terminal half ('falf-WAF'). Oncogene 11:393-395.